McKesson Corporation $MCK is Meyer Handelman Co.’s 7th Largest Position

Meyer Handelman Co. lifted its position in shares of McKesson Corporation (NYSE:MCK) by 3.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 104,906 shares of the company’s stock after purchasing an additional 3,520 shares during the period. McKesson accounts for about 2.7% of Meyer Handelman Co.’s holdings, making the stock its 7th biggest position. Meyer Handelman Co. owned approximately 0.08% of McKesson worth $86,053,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. GGM Financials LLC purchased a new stake in McKesson in the 3rd quarter valued at about $25,000. State of Wyoming purchased a new position in shares of McKesson in the 2nd quarter worth approximately $29,000. Hopwood Financial Services Inc. bought a new position in shares of McKesson in the third quarter valued at approximately $31,000. Board of the Pension Protection Fund bought a new position in shares of McKesson in the fourth quarter valued at approximately $33,000. Finally, Vermillion & White Wealth Management Group LLC purchased a new stake in shares of McKesson during the third quarter valued at approximately $33,000. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

McKesson Trading Up 0.6%

MCK opened at $864.99 on Wednesday. The company has a 50 day moving average of $908.89 and a 200 day moving average of $842.77. The company has a market cap of $105.95 billion, a PE ratio of 24.88, a price-to-earnings-growth ratio of 1.38 and a beta of 0.38. McKesson Corporation has a 12 month low of $637.00 and a 12 month high of $999.00.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. The business had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Research analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be paid a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Monday, March 2nd. McKesson’s payout ratio is presently 9.43%.

Wall Street Analyst Weigh In

A number of brokerages recently commented on MCK. Morgan Stanley reiterated an “overweight” rating and set a $966.00 price target on shares of McKesson in a report on Thursday, January 29th. Mizuho raised their target price on McKesson from $880.00 to $885.00 and gave the company a “neutral” rating in a research report on Thursday, February 5th. TD Cowen lifted their target price on McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Evercore reissued an “outperform” rating on shares of McKesson in a report on Thursday, March 5th. Finally, Barclays increased their price target on shares of McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a research report on Wednesday, February 18th. Thirteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $960.93.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Thomas L. Rodgers sold 276 shares of McKesson stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $816.18, for a total transaction of $225,265.68. Following the completion of the transaction, the executive vice president owned 2,268 shares of the company’s stock, valued at $1,851,096.24. The trade was a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Leann B. Smith sold 190 shares of the company’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the sale, the executive vice president owned 2,989 shares in the company, valued at approximately $2,824,605. This represents a 5.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 3,868 shares of company stock worth $3,743,820 in the last three months. 0.08% of the stock is currently owned by corporate insiders.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.